APA (7th ed.) Citation

N, S. S., F, S. S., OS, B., S, H., HAH, A., F, K., . . . R, H. (2024). Salivary autoantibodies to type I IFNs: Mirror plasma levels, predispose to severe COVID-19, and enhance feasibility for clinical screening. Heart & lung : the journal of critical care, 66, 31. https://doi.org/10.1016/j.hrtlng.2024.03.005

Chicago Style (17th ed.) Citation

N, Saheb Sharif-Askari, et al. "Salivary Autoantibodies to Type I IFNs: Mirror Plasma Levels, Predispose to Severe COVID-19, and Enhance Feasibility for Clinical Screening." Heart & Lung : The Journal of Critical Care 66 (2024): 31. https://doi.org/10.1016/j.hrtlng.2024.03.005.

MLA (9th ed.) Citation

N, Saheb Sharif-Askari, et al. "Salivary Autoantibodies to Type I IFNs: Mirror Plasma Levels, Predispose to Severe COVID-19, and Enhance Feasibility for Clinical Screening." Heart & Lung : The Journal of Critical Care, vol. 66, 2024, p. 31, https://doi.org/10.1016/j.hrtlng.2024.03.005.